financetom
Market
financetom
/
Market
/
TREASURIES-US yields slide after weaker-than-expected jobs, ISM data
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
TREASURIES-US yields slide after weaker-than-expected jobs, ISM data
Jul 3, 2024 9:05 AM

(Adds ISM data in paragraph 2, analyst note in paragraph 4)

By David Randall

NEW YORK, July 3 (Reuters) - Benchmark 10-year Treasury

yields fell on Wednesday after growing signs of weakness in

manufacturing and the jobs market suggested the U.S. economy was

slowing.

The ISM Non-Manufacturing index came in at 48.8 in June,

well below the consensus of 52.5 and the 53.8 level in May.

Initial claims for unemployment rose 238,000 in the week ended

June 29, slightly above expectations of 235,000, and up from

234,000 the prior week, the Labor Department said.

Data released earlier in the day by ADP showed private

payrolls rose by 150,000 jobs in June, below consensus estimates

of an increase of 160,000.

"The economy seems to have weakened at quarter-end," said

Bill Adams, chief economist for Comerica Bank.

The Federal Reserve has cited the labor market's resilience

in the face of interest rates at nearly two-decade highs as one

reason why it has yet to cut rates. Futures markets are pricing

in roughly 45 basis points in cumulative rate cuts by the end of

the year.

The benchmark U.S. 10-year Treasury note yield

fell 8.9 basis points to 4.347%. The yield on the 30-year bond

dropped 8.5 basis points to 4.524%.

The two-year U.S. Treasury yield, which typically

moves in step with interest rate expectations, fell 5.4 basis

points to 4.685%.

A closely watched part of the U.S. Treasury yield curve

measuring the gap between yields on two- and 10-year Treasury

notes, an indicator of economic expectations, was

at a negative 34.0 basis points. It had touched its least

shallow inversion since May earlier in the week.

The bond market will close at 2 p.m. ET ahead of the July

Fourth U.S. Independence Day holiday and will reopen on Friday.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Sector Update: Tech
Sector Update: Tech
Jun 17, 2024
03:39 PM EDT, 06/17/2024 (MT Newswires) -- Tech stocks were higher in late Monday afternoon trading, with the Technology Select Sector SPDR Fund (XLK) adding 1.8% and the SPDR S&P Semiconductor ETF (XSD) up 0.6%. The Philadelphia Semiconductor index rose 1.7%. In corporate news, Autodesk ( ADSK ) shareholder Starboard Value said Monday that it plans to sue Autodesk (...
US STOCKS-Wall Street advances as investors eye economic data, Fed comments
US STOCKS-Wall Street advances as investors eye economic data, Fed comments
Jun 17, 2024
* Goldman Sachs ( GS ) raises S&P 500 year-end target to 5,600 points * Evercore ISI hikes year-end S&P 500 target to 6,000 points * Autodesk ( ADSK ) up after report Starboard Value takes ~$500 mln stake * Indexes higher: Dow 0.56%, S&P 500 1.02%, Nasdaq 1.34% (As of 2:15 p.m eastern) By Echo Wang June 17 (Reuters)...
Top Midday Decliners
Top Midday Decliners
Jun 17, 2024
02:31 PM EDT, 06/17/2024 (MT Newswires) -- Aerovate Therapeutics ( AVTE ) said Monday its AV-101 drug candidate did not meet its primary endpoint during phase 2b trial. After the trial results, Jefferies downgraded the stock to hold from buy while cutting its price target to $2 from $65, and Wells Fargo to equalweight from overweight. Shares plummeted 92% as...
Sector Update: Health Care
Sector Update: Health Care
Jun 17, 2024
03:39 PM EDT, 06/17/2024 (MT Newswires) -- Health care stocks dropped late Monday afternoon with the NYSE Health Care Index down 0.4% and the Health Care Select Sector SPDR Fund (XLV) eased 0.1%. The iShares Biotechnology ETF (IBB) fell 0.6%. In corporate news, Aerovate Therapeutics ( AVTE ) shares plunged 93% after the company said its AV-101 drug candidate failed...
Copyright 2023-2025 - www.financetom.com All Rights Reserved